SCHEMBL21723726

SCHEMBL21723726

O=C(O)NCCC(=O)Nc1cnc2cc(Br)ccc2c1NC1CCC1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TERT O14746 4/20 0.39
SMN1; SMN2 Q16637 2/20 0.35
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.35
RAB9A P51151 1/20 0.35
KMT2A Q03164 1/20 0.35
AAK1 Q2M2I8 1/20 0.33
BACE1 P56817 1/20 0.33
PDGFRA P16234 1/20 0.33
LRRK2 Q5S007 1/20 0.33
KRAS P01116 1/20 0.33
EGLN2 Q96KS0 1/20 0.33
EGLN1 Q9GZT9 1/20 0.33
PREP P48147 1/20 0.33
PDE4B Q07343 1/20 0.33
HDAC3 O15379 1/20 0.32
HDAC1 Q13547 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21723944 0.87 GBA1 (0.38) TERTAAK1
SCHEMBL21723968 0.80 EHMT2 (0.40) SMN1; SMN2KMT2ABACE1
SCHEMBL21723986 0.71 IRAK4 (0.40) PDGFRALRRK2PDE4B
SCHEMBL21733005 0.69 POLB (0.34) KMT2APDE4B
SCHEMBL21724000 0.69 PTGES (0.42) KMT2AMAPT
SCHEMBL2113617 0.67 KCNH2 (0.41) AAK1LRRK2
SCHEMBL17272549 0.67 PDE4B (0.52) PDE4B
SCHEMBL3861888 0.67 MAPK1 (0.41) ALDH1A1MAPT
SCHEMBL23037527 0.67 KDM4E (0.42) NPC1RAB9AKMT2AAAK1PDGFRA
SCHEMBL5146626 0.67 GSK3B (0.49) SMN1; SMN2NPC1ALDH1A1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3837015-A1 IMIDAZO[4,5-C]QUINOLINE DERIVED NLRP3-MODULATORS Innate Tumor Immunity, Inc. (US) 2021-06-23 EP disclosed
WO-2020037092-A1 IMIDAZO[4,5-C]QUINOLINE DERIVED NLRP3-MODULATORS INNATE TUMOR IMMUNITY, INC. (US) 2020-02-20 WO disclosed